I agree that this site is using cookies. You can find further informations here.
X
Palmieri, Raffaele
331  results:
Search for persons X
?
1

Literature review and expert opinion on the treatment of hi..:

Palmieri, Raffaele ; Billio, Atto ; Ferrara, Felicetto...
Frontiers in Oncology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

The ISTH DIC-score predicts early mortality in patients wit..:

Paterno, Giovangiacinto ; Palmieri, Raffaele ; Tesei, Cristiano...
Thrombosis Research.  236 (2024)  - p. 30-36 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Optimal Prognostic Threshold for Acute Myeloid Leukemia (AM..:

Rodríguez-Arbolí, Eduardo ; Othus, Megan ; Freeman, Sylvie...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S9 , 2024
Link: https://doi.org/10.1016/..
 
?
4

THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIE..:

Palmieri, Raffaele ; Del Principe, Ilaria ; Maurillo, Luca..
Mediterranean Journal of Hematology and Infectious Diseases.  15 (2023)  1 - p. e2023051 , 2023
Link: https://doi.org/10.4084/..
 
?
5

FEVER OF UNKNOWNORIGIN AND MULTIDRUG-RESISTANT ORGANISMS CO..:

Guarnera, Luca ; Trotta, Gentiana Elena ; Boldrini, Valentina...
Mediterranean Journal of Hematology and Infectious Diseases.  15 (2023)  1 - p. e2023013 , 2023
Link: https://doi.org/10.4084/..
 
?
6

Efficacy and safety of nilotinib as frontline treatment in ..:

Luciano, Luigia ; Latagliata, Roberto ; Gugliotta, Gabriele...
Annals of Hematology.  102 (2023)  6 - p. 1375-1382 , 2023
Link: https://doi.org/10.1007/..
 
?
7

P505: GIMEMA AML1819 TRIAL: GEMTUZUMAB OZOGAMICIN PLUS INTE..:

Venditti, Adriano ; Piciocchi, Alfonso ; Maurillo, Luca...
HemaSphere.  7 (2023)  S3 - p. e8415389 , 2023
Link: https://doi.org/10.1097/..
 
?
8

P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED ..:

Tettero, Jesse ; Palmieri, Raffaele ; Lam Ngai, Lok...
HemaSphere.  7 (2023)  S3 - p. e18625e3 , 2023
Link: https://doi.org/10.1097/..
 
?
9

P523: THE COMPARISON OF VFLAI, FLAI AND 3 + 7 REGIMENS BY M..:

Piciocchi, Alfonso ; Marconi, Giovanni ; Cipriani, Marta...
HemaSphere.  7 (2023)  S3 - p. e0034216 , 2023
Link: https://doi.org/10.1097/..
 
?
10

Real‐world efficacy and safety of luspatercept and predicti..:

Lanino, Luca ; Restuccia, Francesco ; Perego, Alessandra...
American Journal of Hematology.  98 (2023)  8 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
11

Editorial: Measurable residual disease in hematologic malig..:

Buccisano, Francesco ; Palmieri, Raffaele ; Guzman, Monica L..
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
12

Measurable Residual Disease (MRD) as a Surrogate Efficacy-R..:

Meddi, Elisa ; Savi, Arianna ; Moretti, Federico...
International Journal of Molecular Sciences.  24 (2023)  4 - p. 3062 , 2023
Link: https://doi.org/10.3390/..
 
?
13

Predictors of Early Thrombotic Events in Adult Patients wit..:

Paterno, Giovangiacinto ; Palmieri, Raffaele ; Forte, Vittorio...
Cancers.  14 (2022)  22 - p. 5640 , 2022
Link: https://doi.org/10.3390/..
 
?
14

Allogeneic stem cell transplantation in patients with a pri..:

Palmieri, Raffaele ; Montgomery, Robert B. ; Doney, Kristine
Annals of Hematology.  102 (2022)  2 - p. 407-412 , 2022
Link: https://doi.org/10.1007/..
 
?
15

Impairment of FOXM1 expression in mesenchymal cells from pa..:

Falconi, Giulia ; Galossi, Elisa ; Fabiani, Emiliano...
Scientific Reports.  12 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
1-15